Lymphatic Mapping in Colon Cancer Depending on Injection Time and Tracing Agent: A Systematic Review and Meta-Analysis of Prospective Designed Studies

An optimized lymph node yield leads to better survival in colon cancer, but extended lymphadenectomy is not associated with survival benefits. Lymphatic mapping shows several colon cancers feature aberrant drainage pathways inducing local recurrence when not resected. Currently, different protocols...

Full description

Bibliographic Details
Main Authors: Katharina Lucas, Nathaniel Melling, Anastasios D. Giannou, Matthias Reeh, Oliver Mann, Thilo Hackert, Jakob R. Izbicki, Daniel Perez, Julia K. Grass
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/12/3196
_version_ 1797436094976884736
author Katharina Lucas
Nathaniel Melling
Anastasios D. Giannou
Matthias Reeh
Oliver Mann
Thilo Hackert
Jakob R. Izbicki
Daniel Perez
Julia K. Grass
author_facet Katharina Lucas
Nathaniel Melling
Anastasios D. Giannou
Matthias Reeh
Oliver Mann
Thilo Hackert
Jakob R. Izbicki
Daniel Perez
Julia K. Grass
author_sort Katharina Lucas
collection DOAJ
description An optimized lymph node yield leads to better survival in colon cancer, but extended lymphadenectomy is not associated with survival benefits. Lymphatic mapping shows several colon cancers feature aberrant drainage pathways inducing local recurrence when not resected. Currently, different protocols exist for lymphatic mapping procedures. This meta-analysis assessed which protocol has the best capacity to detect tumor-draining and possibly metastatic lymph nodes. A systematic review was conducted according to PRISMA guidelines, including prospective trials with in vivo tracer application. The risk of bias was evaluated using the QUADAS-2 tool. Traced lymph nodes, total resected lymph nodes, and aberrant drainage detection rate were analyzed. Fifty-eight studies met the inclusion criteria, of which 42 searched for aberrant drainage. While a preoperative tracer injection significantly increased the traced lymph node rates compared to intraoperative tracing (30.1% (15.4, 47.3) vs. 14.1% (11.9, 16.5), <i>p</i> = 0.03), no effect was shown for the tracer used (<i>p</i> = 0.740) or the application sites comparing submucosal and subserosal injection (22.9% (14.1, 33.1) vs. 14.3% (12.1, 16.8), <i>p</i> = 0.07). Preoperative tracer injection resulted in a significantly higher rate of detected aberrant lymph nodes compared to intraoperative injection (26.3% [95% CI 11.5, 44.0] vs. 2.5% [95% CI 0.8, 4.7], <i>p</i> < 0.001). Analyzing 112 individual patient datasets from eight studies revealed a significant impact on aberrant drainage detection for injection timing, favoring preoperative over intraoperative injection (OR 0.050 [95% CI 0.010–0.176], <i>p</i> < 0.001) while indocyanine green presented itself as the superior tracer (OR 0.127 [95% CI 0.018–0.528], <i>p</i> = 0.012). Optimized lymphatic mapping techniques result in significantly higher detection of aberrant lymphatic drainage patterns and thus enable a personalized approach to reducing local recurrence.
first_indexed 2024-03-09T10:57:44Z
format Article
id doaj.art-e896ef3d5b9d4ded856ab19928986745
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T10:57:44Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-e896ef3d5b9d4ded856ab199289867452023-12-01T01:32:40ZengMDPI AGCancers2072-66942023-06-011512319610.3390/cancers15123196Lymphatic Mapping in Colon Cancer Depending on Injection Time and Tracing Agent: A Systematic Review and Meta-Analysis of Prospective Designed StudiesKatharina Lucas0Nathaniel Melling1Anastasios D. Giannou2Matthias Reeh3Oliver Mann4Thilo Hackert5Jakob R. Izbicki6Daniel Perez7Julia K. Grass8Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, GermanyDepartment of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, GermanyDepartment of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, GermanyDepartment of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, GermanyDepartment of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, GermanyDepartment of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, GermanyDepartment of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, GermanyDepartment of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, GermanyDepartment of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, GermanyAn optimized lymph node yield leads to better survival in colon cancer, but extended lymphadenectomy is not associated with survival benefits. Lymphatic mapping shows several colon cancers feature aberrant drainage pathways inducing local recurrence when not resected. Currently, different protocols exist for lymphatic mapping procedures. This meta-analysis assessed which protocol has the best capacity to detect tumor-draining and possibly metastatic lymph nodes. A systematic review was conducted according to PRISMA guidelines, including prospective trials with in vivo tracer application. The risk of bias was evaluated using the QUADAS-2 tool. Traced lymph nodes, total resected lymph nodes, and aberrant drainage detection rate were analyzed. Fifty-eight studies met the inclusion criteria, of which 42 searched for aberrant drainage. While a preoperative tracer injection significantly increased the traced lymph node rates compared to intraoperative tracing (30.1% (15.4, 47.3) vs. 14.1% (11.9, 16.5), <i>p</i> = 0.03), no effect was shown for the tracer used (<i>p</i> = 0.740) or the application sites comparing submucosal and subserosal injection (22.9% (14.1, 33.1) vs. 14.3% (12.1, 16.8), <i>p</i> = 0.07). Preoperative tracer injection resulted in a significantly higher rate of detected aberrant lymph nodes compared to intraoperative injection (26.3% [95% CI 11.5, 44.0] vs. 2.5% [95% CI 0.8, 4.7], <i>p</i> < 0.001). Analyzing 112 individual patient datasets from eight studies revealed a significant impact on aberrant drainage detection for injection timing, favoring preoperative over intraoperative injection (OR 0.050 [95% CI 0.010–0.176], <i>p</i> < 0.001) while indocyanine green presented itself as the superior tracer (OR 0.127 [95% CI 0.018–0.528], <i>p</i> = 0.012). Optimized lymphatic mapping techniques result in significantly higher detection of aberrant lymphatic drainage patterns and thus enable a personalized approach to reducing local recurrence.https://www.mdpi.com/2072-6694/15/12/3196colon cancerlymphatic mappinglymph node metastasesaberrant drainageICGcurative surgery
spellingShingle Katharina Lucas
Nathaniel Melling
Anastasios D. Giannou
Matthias Reeh
Oliver Mann
Thilo Hackert
Jakob R. Izbicki
Daniel Perez
Julia K. Grass
Lymphatic Mapping in Colon Cancer Depending on Injection Time and Tracing Agent: A Systematic Review and Meta-Analysis of Prospective Designed Studies
Cancers
colon cancer
lymphatic mapping
lymph node metastases
aberrant drainage
ICG
curative surgery
title Lymphatic Mapping in Colon Cancer Depending on Injection Time and Tracing Agent: A Systematic Review and Meta-Analysis of Prospective Designed Studies
title_full Lymphatic Mapping in Colon Cancer Depending on Injection Time and Tracing Agent: A Systematic Review and Meta-Analysis of Prospective Designed Studies
title_fullStr Lymphatic Mapping in Colon Cancer Depending on Injection Time and Tracing Agent: A Systematic Review and Meta-Analysis of Prospective Designed Studies
title_full_unstemmed Lymphatic Mapping in Colon Cancer Depending on Injection Time and Tracing Agent: A Systematic Review and Meta-Analysis of Prospective Designed Studies
title_short Lymphatic Mapping in Colon Cancer Depending on Injection Time and Tracing Agent: A Systematic Review and Meta-Analysis of Prospective Designed Studies
title_sort lymphatic mapping in colon cancer depending on injection time and tracing agent a systematic review and meta analysis of prospective designed studies
topic colon cancer
lymphatic mapping
lymph node metastases
aberrant drainage
ICG
curative surgery
url https://www.mdpi.com/2072-6694/15/12/3196
work_keys_str_mv AT katharinalucas lymphaticmappingincoloncancerdependingoninjectiontimeandtracingagentasystematicreviewandmetaanalysisofprospectivedesignedstudies
AT nathanielmelling lymphaticmappingincoloncancerdependingoninjectiontimeandtracingagentasystematicreviewandmetaanalysisofprospectivedesignedstudies
AT anastasiosdgiannou lymphaticmappingincoloncancerdependingoninjectiontimeandtracingagentasystematicreviewandmetaanalysisofprospectivedesignedstudies
AT matthiasreeh lymphaticmappingincoloncancerdependingoninjectiontimeandtracingagentasystematicreviewandmetaanalysisofprospectivedesignedstudies
AT olivermann lymphaticmappingincoloncancerdependingoninjectiontimeandtracingagentasystematicreviewandmetaanalysisofprospectivedesignedstudies
AT thilohackert lymphaticmappingincoloncancerdependingoninjectiontimeandtracingagentasystematicreviewandmetaanalysisofprospectivedesignedstudies
AT jakobrizbicki lymphaticmappingincoloncancerdependingoninjectiontimeandtracingagentasystematicreviewandmetaanalysisofprospectivedesignedstudies
AT danielperez lymphaticmappingincoloncancerdependingoninjectiontimeandtracingagentasystematicreviewandmetaanalysisofprospectivedesignedstudies
AT juliakgrass lymphaticmappingincoloncancerdependingoninjectiontimeandtracingagentasystematicreviewandmetaanalysisofprospectivedesignedstudies